Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
LifeStance Health GroupLFST -0.73%54 Price-to-Tangible-Book is 780.00 as of Jul. 23, 2026, which is 569% above its 10-year median of 116.57. GuruFocus rates LFST with a GF Score™ of 54/100 and a GF Value™ of $8.31 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 503 Healthcare Providers & Services companies, LifeStance Health Group ranks worse than 100% on this metric.
The historical rank and industry rank for LifeStance Health Group's Price-to-Tangible-Book or its related term are showing as below:
LFST'
s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 54.57 Med: 116.57 Max: 1101
Current: 1092
During the past 7 years, LifeStance Health Group's highest Price to Tangible Book Ratio was 1101.00. The lowest was 54.57. And the median was 116.57.
LFST's Price-to-Tangible-Book is ranked worse than 100% of 503
companies
in the Healthcare Providers & Services industry
Industry Median: 2.64
vs LFST: 1092.00
Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.
LifeStance Health Group Price-to-Tangible-Book Related Terms
LifeStance Health Group Price-to-Tangible-Book Historical Data
* Premium members only.
The historical data trend for LifeStance Health Group's Price-to-Tangible-Book can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group Price-to-Tangible-Book Chart
LFST vs CON, BKD, OPCH: Price-to-Tangible-Book Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group Price-to-Tangible-Book vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's Price-to-Tangible-Book distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's Price-to-Tangible-Book falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.
What does a Price-to-Tangible-Book of 780.00 mean?
LifeStance Health Group (LFST) has a Price-to-Tangible-Book of 780.00 as of Jul. 23, 2026. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on LifeStance Health Group and its competitors. This is 569% above median its historical median of 116.57. Over the past decade, LifeStance Health Group's Price-to-Tangible-Book has ranged from 54.57 to 1,101.00. According to the industry distribution chart, LifeStance Health Group ranks #503 out of 503 companies in the Healthcare Providers & Services industry.
Is LifeStance Health Group's Price-to-Tangible-Book too high?
LifeStance Health Group's current Price-to-Tangible-Book of 780.00 is 569% above median its 10-year median of 116.57. Over the past 10 years, this metric has ranged from a low of 54.57 to a high of 1,101.00. The Healthcare Providers & Services industry median Price-to-Tangible-Book is 2.64. LifeStance Health Group's value of 780.00 is 29445.5% above this industry median. Based on the distribution chart, LifeStance Health Group ranks #503 out of 503 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, LifeStance Health Group has a GF Score™ of 54/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's Price-to-Tangible-Book compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #503 out of 503 companies for Price-to-Tangible-Book. This places LifeStance Health Group in the lower half of its industry. The industry median Price-to-Tangible-Book is 2.64. LifeStance Health Group's value of 780.00 is 29445.5% above this benchmark. Historically, LifeStance Health Group's own Price-to-Tangible-Book has ranged from 54.57 to 1,101.00 over the past decade. While the company's 10-year median is 116.57 vs. the industry median of 2.64, LifeStance Health Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Price-to-Tangible-Book for a Healthcare Providers & Services company?
The median Price-to-Tangible-Book among Healthcare Providers & Services companies is 2.64, based on 503 companies in the industry. Companies in the top quartile (top 25%) have a Price-to-Tangible-Book significantly above this median, while those in the bottom quartile fall well below. However, Price-to-Tangible-Book should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. LifeStance Health Group's current Price-to-Tangible-Book of 780.00 is 29445.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Price-to-Tangible-Book mean?
A high Price-to-Tangible-Book can signal that a stock is expensive relative to its fundamentals. Price-to-tangible-book ratio is the ratio of share price to a company's tangible book value per share. View historical data on LifeStance Health Group and its competitors. For the Healthcare Providers & Services industry, the median Price-to-Tangible-Book is 2.64 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. LifeStance Health Group's current Price-to-Tangible-Book is 780.00, which is 569% above median its own 10-year median of 116.57. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.31, compared to a current price of $10.92 — trading 31.4% above its estimated fair value. The current Price-to-Tangible-Book is 780.00, which is 569% above median its 10-year median of 116.57 and 29445.5% above the Healthcare Providers & Services industry median of 2.64. LifeStance Health Group's overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Price-to-Tangible-Book calculated?
Price-to-Tangible-Book is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current Price-to-Tangible-Book is 780.00 as of Jul. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $10.92 is trading 31.4% above its estimated GF Value™ of $8.31.
GuruFocus considers LifeStance Health Group to be Significantly Overvalued.
Key valuation signals for LFST:
Price-to-Tangible-Book: 780.00 (569% above median its 10-year median of 116.57)
GF Value™: $8.31 vs. price of $10.92 (31.4% above fair value)
Industry Position: 29445.5% above the Healthcare Providers & Services median (#503 of 503)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
54GF Score
Get the complete analysis for LFST
Price-to-Tangible-Book is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 
